Recombinant Guinea pig HRH2 is synthesized using multiple expression systems, including:
| Product Code | Expression System | Purity | Source |
|---|---|---|---|
| CSB-CF010738GU | E. coli | ≥90% (SDS-PAGE) | Cusabio |
| CSB-YP010738GU1 | Yeast | ≥85% | Creative BioMart |
| CSB-EP010738GU1-B | Baculovirus | ≥95% | Creative BioMart |
These systems enable large-scale production for applications like ELISA, Western blot, and functional assays .
Guinea pig HRH2 exhibits lower basal constitutive activity than canine HRH2 but higher than human or rat isoforms .
Ligand-specific conformations influence receptor behavior. For example:
Binds histamine to activate Gsα proteins, increasing cAMP via adenylate cyclase .
Cross-talks with H1 receptors, modulating cAMP and IP3 pathways in cardiomyocytes .
In Guinea pig hearts, HRH2 agonists increase contractility without affecting heart rate .
Heterodimerization with H1 receptors alters downstream signaling, as observed in transfected CHO cells .
Used to model histamine-induced acid secretion in parietal cells, informing therapies for ulcers and GERD .
Screens for H2 antagonists (e.g., cimetidine) leverage Guinea pig HRH2 due to its ligand-binding similarities to human receptors .
| Pathway | Associated Proteins |
|---|---|
| Neuroactive ligand-receptor interaction | HTR6, HRH1, HRH3, HRH4 |
| Calcium signaling | PLC, PKC, TRPC channels |
STRING: 10141.ENSCPOP00000003138
The guinea pig histamine H2 receptor is encoded by an intronless DNA sequence that produces a 359 amino acid protein. Northern blot analysis has identified a single transcript of 4.6 kb in peripheral tissues and brain areas. The receptor displays significant homology (83-86% identity) with rat, human, and dog H2 receptors, reflecting its evolutionary conservation across mammalian species .
The guinea pig H2 receptor was cloned using a strategy based on nucleotide sequence homology, starting from the rat histamine H2 receptor sequence (Ruat et al., 1991). This approach successfully identified a highly homologous DNA sequence encoding the guinea pig H2 receptor . The cloning strategy leveraged the conserved regions between species to design appropriate primers and probes for isolating the guinea pig receptor gene.
Through Southern analysis of a chromosome mapping panel constructed from human x hamster hybridomas, researchers assigned the H2 receptor gene to human chromosome 5 . This chromosomal localization provides important information for comparative genomic studies and understanding potential regulatory mechanisms.
The H2 receptor shows a distinctive expression pattern in guinea pigs. Northern blot analysis and in situ hybridization studies have revealed H2 receptor transcripts in various peripheral tissues and specific brain areas. The distribution of these transcripts is consistent with locations previously identified through photoaffinity labeling or binding studies . This expression pattern provides valuable information for researchers selecting appropriate tissues for receptor isolation or functional studies.
While the search results don't directly address expression systems for guinea pig H2 receptors, researchers typically use mammalian cell lines (such as HEK293 or CHO cells) for G-protein coupled receptor expression. These systems provide the appropriate cellular machinery for receptor folding, post-translational modifications, and functional coupling to signaling pathways. For structural studies, insect cell lines and yeast expression systems might be considered, though each has specific advantages and limitations for histamine receptor research.
The guinea pig H2 receptor shows some pharmacological differences compared to other species, similar to the documented species variations in H3 receptors. While histamine receptors show high sequence conservation across species (>90%), they can exhibit significant species-specific pharmacological properties in terms of ligand binding affinities and functional responses . These differences highlight the importance of species-appropriate models when evaluating H2 receptor ligands.
Functional assays for guinea pig H2 receptor typically include measurements of cAMP production (as H2 receptors couple primarily to Gs proteins), receptor binding assays with radiolabeled ligands, and calcium mobilization assays. In guinea pig models, researchers can also measure physiological parameters like heart rate, arterial pressure, and body temperature in response to receptor activation or blockade . These multiple approaches provide complementary information about receptor function.
When designing experiments with recombinant guinea pig H2 receptor, researchers should consider:
Expression system selection based on research objectives
Validation of receptor expression and functionality
Selection of appropriate control conditions
Choice of detection methods with sufficient sensitivity
Potential for receptor desensitization during prolonged stimulation
Species-specific pharmacology when selecting ligands
Post-translational modifications that might affect receptor function
These considerations ensure robust and reproducible results when working with recombinant H2 receptors.
For optimal transfection efficiency when expressing recombinant guinea pig H2 receptor:
Select a mammalian cell line with high transfectability and low endogenous H2 receptor expression
Optimize DNA:transfection reagent ratios through systematic testing
Consider stable cell line development for consistent receptor expression
Validate receptor expression through immunoblotting, flow cytometry, or binding assays
Ensure cells are in optimal growth phase during transfection (typically 70-80% confluency)
Use serum-free media during transfection to prevent interference from serum components
Guinea pigs have historically been the prototypic animal species for histamine H2 receptor research . They offer several advantages:
High sensitivity to histamine, making physiological responses readily measurable
Histamine receptor distribution pattern similar to humans
Established experimental protocols and extensive literature base
Appropriate size for physiological measurements and tissue collection
Well-characterized pharmacological responses to standard H2 ligands
These advantages make guinea pigs particularly valuable for translational histamine receptor research.
Site-directed mutagenesis of the guinea pig H2 receptor allows researchers to systematically modify specific amino acid residues to determine their role in ligand binding, receptor activation, and signal transduction. By comparing mutated receptors with wild-type, researchers can identify:
Critical binding pocket residues for histamine and synthetic ligands
Amino acids involved in receptor activation mechanisms
Residues responsible for species-specific pharmacological differences
Domains important for G-protein coupling specificity
These studies provide molecular-level insights into receptor function that can guide drug discovery efforts.
To investigate potential dimerization or oligomerization of guinea pig H2 receptors, researchers can employ:
Bioluminescence resonance energy transfer (BRET) or fluorescence resonance energy transfer (FRET) with differentially tagged receptors
Co-immunoprecipitation of differently tagged receptor variants
Cross-linking studies followed by size-exclusion chromatography
Functional complementation assays with receptor fragments
Single-molecule imaging techniques to visualize receptor complexes
These approaches help determine whether H2 receptors function as monomers or form higher-order structures that might influence signaling properties.
Common challenges when working with recombinant guinea pig H2 receptor include:
| Challenge | Potential Solutions |
|---|---|
| Low expression levels | Optimize codon usage, use stronger promoters, consider alternative expression systems |
| Receptor misfolding | Adjust culture temperature, include chaperone proteins, optimize signal peptide |
| Constitutive activity | Use inverse agonists or salt concentration adjustments to stabilize inactive state |
| Rapid desensitization | Use pulse stimulation protocols, include phosphatase inhibitors |
| High background in functional assays | Include appropriate controls, reduce expression of endogenous receptors |
| Species-specific pharmacology | Always validate ligands with guinea pig receptor before extensive studies |
To differentiate specific H2 receptor effects from non-specific effects:
Include appropriate negative controls (untransfected cells, cells expressing irrelevant receptors)
Use multiple structurally distinct H2 receptor antagonists to block responses
Implement siRNA knockdown or CRISPR editing to reduce receptor expression
Compare concentration-response relationships with known receptor pharmacology
Utilize reporter systems specifically coupled to H2 receptor signaling pathways
Conduct parallel experiments in expression systems lacking endogenous histamine receptors
These approaches increase confidence that observed effects are mediated specifically through the H2 receptor.
The advancement of guinea pig genomics, including projects like the Guinea Pig Genome Project by The Broad Institute, significantly enhances guinea pig research capabilities . These genomic resources enable:
More precise genetic manipulation of guinea pig H2 receptors
Identification of species-specific regulatory elements
Development of transgenic guinea pig models
Improved understanding of receptor gene structure and splice variants
Comprehensive analysis of histamine receptor family evolution
Better primer and probe design for molecular studies
These genomic advances will likely accelerate progress in histamine receptor research using guinea pig models.
Emerging applications of recombinant guinea pig H2 receptor in drug discovery include:
High-throughput screening platforms for novel H2 ligands
Structure-based drug design using homology models of the guinea pig receptor
Development of bispecific antibodies targeting H2 receptors and other therapeutic targets
Evaluation of species selectivity during early drug development
Creation of guinea pig disease models expressing mutant H2 receptors
Investigation of biased signaling pathways for therapeutic exploitation
These applications leverage the guinea pig model's historical importance while incorporating modern drug discovery technologies.